Arcutis Biotherapeutics Inc (ARQT)
8.36
-0.30
(-3.46%)
USD |
NASDAQ |
May 31, 16:00
8.35
-0.01
(-0.12%)
Pre-Market: 20:00
Arcutis Biotherapeutics Shareholders Equity (Quarterly): 224.94M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 224.94M |
| December 31, 2023 | 88.67M |
| September 30, 2023 | 46.72M |
| June 30, 2023 | 80.51M |
| March 31, 2023 | 139.73M |
| December 31, 2022 | 209.58M |
| September 30, 2022 | 270.77M |
| June 30, 2022 | 195.38M |
| March 31, 2022 | 253.77M |
| December 31, 2021 | 297.68M |
| Date | Value |
|---|---|
| September 30, 2021 | 363.00M |
| June 30, 2021 | 414.49M |
| March 31, 2021 | 450.99M |
| December 31, 2020 | 270.62M |
| September 30, 2020 | 173.07M |
| June 30, 2020 | 208.92M |
| March 31, 2020 | 241.88M |
| December 31, 2019 | -65.03M |
| September 30, 2019 | -52.95M |
| December 31, 2018 | -23.99M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-65.03M
Minimum
Dec 2019
450.99M
Maximum
Mar 2021
200.67M
Average
209.58M
Median
Dec 2022
Shareholders Equity (Quarterly) Benchmarks
| Heron Therapeutics Inc | -33.77M |
| Marinus Pharmaceuticals Inc | -16.43M |
| Insmed Inc | -464.81M |
| Agios Pharmaceuticals Inc | 743.92M |
| AdaptHealth Corp | 1.462B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 478.54M |
| Total Liabilities (Quarterly) | 253.60M |
| Debt to Equity Ratio | 0.9016 |
| Current Ratio | 9.894 |
| Net Debt Paydown Yield | -0.09% |